New, long‐acting, potent bradykinin antagonists

British Journal of Pharmacology - Tập 102 Số 2 - Trang 297-304 - 1991
Fred Lembeck1, Thomas Griesbacher1, Martin Eckhardt1, S. Henke2, Gerhard Breipohl2, Jochen Knolle2
1Department of Experimental and Clinical Pharmacology, University of Graz, Universitätsplatz 4, A-8010 Graz, Austria
2Hoechst AG, P.O. Box 800320, D-6230 Frankfurt/Main 80, F.R.G.

Tóm tắt

Three new bradykinin (BK) antagonists, d‐Arg0‐Hyp3‐Thi5‐d‐Tic7‐Oic8‐BK (compound I), d‐Arg0‐Hyp3‐d‐Tic7‐Oic8‐BK (compound II), and Arg(Tos)1‐Hyp3‐Thi5‐d‐Tic7‐Oic8‐BK (compound III), were tested against the effects of BK in 9 bioassay preparations including visceral smooth muscles, vasoconstriction, plasma protein extravasation, release of prostaglandin E2, bronchoconstriction, and stimulation of afferent C‐fibre nociceptors. In some of these tests the effects of the new compounds were compared with those of the antagonist d‐Arg0‐Hyp2‐Thi5,8‐d‐Phe7‐BK (compound IV), described by Stewart & Vavrek (1987). For all bioassays the general rank order of potency of the compounds was found to be I > II > III ≫ IV. The new antagonists were long‐acting; in some bioassays their effects outlasted the duration of the experiment. The inhibitory effects of the new BK antagonists were specific for BK; actions of noradrenaline, angiotensin II, acetylcholine or histamine were unaffected by the antagonists. They did not stimulate the release of histamine or prostaglandins. An agonistic effect was observed only with very high concentrations of compounds I and II in the plasma protein extravasation test. The long duration of action of the new BK antagonists is probably due to a high and long‐lasting affinity to the BK receptors. A high resistance of the antagonists to enzymatic destruction may be another reason. The new BK antagonists will be valuable tools for the investigation of the pathophysiological role of BK. In addition they may offer a potential for therapeutic applications.

Từ khóa


Tài liệu tham khảo

10.1016/0196-9781(90)90107-G

10.1111/j.1476-5381.1984.tb16523.x

10.1016/0014-2999(83)90172-3

CONOVER W.J., 1980, Practical Nonparametric Statistics, 295

FARMER S.G., 1989, Evidence for a pulmonary B3 bradykinin receptor, Mol. Pharmacol., 36, 1

FRANCEL P.C., 1989, Bradykinin analogs antagonize bradykinin‐induced second messenger production in a sensory cell line, Mol. Pharmacol., 35, 34

GEIGY, 1980, Wissenschaftliche Tabellen Geigy (Statistik), 216

10.1111/j.1476-5381.1987.tb11328.x

10.1111/j.1476-5381.1989.tb11850.x

10.1007/978-3-642-94965-4_39

10.1016/0306-4522(87)90049-2

10.1111/j.1476-5381.1989.tb11991.x

10.1007/BF00505082

10.1007/BF00501142

10.1007/BF00411532

10.1002/ddr.430190405

PEREIRA C.C., 1989, Characterization of the receptors responsible for the diphasic effect of bradykinin in rat duodenum, Brazil J. Med. Biol. Res., 22, 1137

10.1111/j.2042-7158.1980.tb12833.x

10.1016/0014-2999(86)90687-4

10.1007/BF00503897

10.1111/j.1476-5381.1987.tb11390.x

10.1073/pnas.85.9.3245

STEWART J.M., 1987, Bradykinin competitive antagonists: design and activities, Adv. Biosci., 65, 73

UEDA N., 1984, Capsaicin and bradykinin‐induced substance P‐ergic responses in the iris sphincter muscle of the rabbit, J. Pharmacol. Exp. Ther., 230, 469

10.1016/0196-9781(85)90033-6

ZAR J.H., 1984, Biostatistical Analysis, 199

Thông tin
Thông tin xuất bản

British Journal of Pharmacology

Tập 102 Số 2

297-304

Thông tin tác giả